A collaborative study of the impact of N-nitrosamines presence and ARB recall on ARB utilization – results from IQVIA™ Disease Analyzer Germany

PURPOSE: Regulators are increasingly concerned with  the impact of recalls on drug adherence. In 2018, N-nitrosamines impurities were detected in valsartan containing medical products. Concerned products were immediately recalled in July 2018 by regulatory agencies internationally. In Germany, recal...

Descripción completa

Detalles Bibliográficos
Autores principales: Hedenmalm, Karin, Quinten, Chantal, Kurz, Xavier, Bradley, Marie, Lee, Hana, Eworuke, Efe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229727/
https://www.ncbi.nlm.nih.gov/pubmed/37095262
http://dx.doi.org/10.1007/s00228-022-03439-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10229727/
https://www.ncbi.nlm.nih.gov/pubmed/37095262
http://dx.doi.org/10.1007/s00228-022-03439-3

Ejemplares similares